292 related articles for article (PubMed ID: 25488178)
1. Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways?
Hermidorff MM; Faria Gde O; Amâncio Gde C; de Assis LV; Isoldi MC
Biochem Cell Biol; 2015 Feb; 93(1):83-93. PubMed ID: 25488178
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism.
Wang M; Li Y; Zhou K; Zhang G; Wang Y; Liu T; Zhang Y; Guo A; An Y
Cell Physiol Biochem; 2016; 39(3):860-70. PubMed ID: 27497962
[TBL] [Abstract][Full Text] [Related]
3. Rapid effects of aldosterone in primary cultures of cardiomyocytes - do they suggest the existence of a membrane-bound receptor?
Araujo CM; Hermidorff MM; Amancio Gde C; Lemos Dda S; Silva ME; de Assis LV; Isoldi MC
J Recept Signal Transduct Res; 2016 Oct; 36(5):435-44. PubMed ID: 27305962
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid and angiotensin receptor antagonism during hyperaldosteronemia.
Mihailidou AS; Mardini M; Funder JW; Raison M
Hypertension; 2002 Aug; 40(2):124-9. PubMed ID: 12154101
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptor antagonists lead to increased adenosine bioavailability and modulate contractile cardiac parameters.
Hermidorff MM; de Assis LVM; Rodrigues JA; Soares LL; Andrade MHG; Natali AJ; Isoldi MC
Heart Vessels; 2020 May; 35(5):719-730. PubMed ID: 31820090
[TBL] [Abstract][Full Text] [Related]
6. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
Moore TD; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone.
Hu X; Li S; McMahon EG; Lala DS; Rudolph AE
Mini Rev Med Chem; 2005 Aug; 5(8):709-18. PubMed ID: 16101407
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of eplerenone in the rat heart: interaction with locally synthesized or blood-derived aldosterone?
Chai W; Garrelds IM; de Vries R; Danser AH
Hypertension; 2006 Apr; 47(4):665-70. PubMed ID: 16490840
[TBL] [Abstract][Full Text] [Related]
9. Differential actions of eplerenone and spironolactone on the protective effect of testosterone against cardiomyocyte apoptosis in vitro.
Sánchez-Más J; Turpín MC; Lax A; Ruipérez JA; Valdés Chávarri M; Pascual-Figal DA
Rev Esp Cardiol; 2010 Jul; 63(7):779-87. PubMed ID: 20609311
[TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
[TBL] [Abstract][Full Text] [Related]
11. Direct effects of aldosterone on cardiomyocytes in the presence of normal and elevated extracellular sodium.
Yamamuro M; Yoshimura M; Nakayama M; Abe K; Shono M; Suzuki S; Sakamoto T; Saito Y; Nakao K; Yasue H; Ogawa H
Endocrinology; 2006 Mar; 147(3):1314-21. PubMed ID: 16373419
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone, but not angiotensin II, reduces angiotensin converting enzyme 2 gene expression levels in cultured neonatal rat cardiomyocytes.
Yamamuro M; Yoshimura M; Nakayama M; Abe K; Sumida H; Sugiyama S; Saito Y; Nakao K; Yasue H; Ogawa H
Circ J; 2008 Aug; 72(8):1346-50. PubMed ID: 18654024
[TBL] [Abstract][Full Text] [Related]
13. Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms.
De Silva DS; Wilson RM; Hutchinson C; Ip PC; Garcia AG; Lancel S; Ito M; Pimentel DR; Sam F
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1983-93. PubMed ID: 19395558
[TBL] [Abstract][Full Text] [Related]
14. Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor.
Rogerson FM; Yao Y; Smith BJ; Fuller PJ
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):704-9. PubMed ID: 15554912
[TBL] [Abstract][Full Text] [Related]
15. The Aldosterone Receptor Antagonist Eplerenone Inhibits Isoproterenol-Induced Collagen-I and 11β-HSD1 Expression in Rat Cardiac Fibroblasts and the Left Ventricle.
Hori Y; Touei D; Saitoh R; Yamagishi M; Kanai K; Hoshi F; Itoh N
Biol Pharm Bull; 2017; 40(10):1716-1723. PubMed ID: 28966243
[TBL] [Abstract][Full Text] [Related]
16. Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone.
Lainscak M; Pelliccia F; Rosano G; Vitale C; Schiariti M; Greco C; Speziale G; Gaudio C
Int J Cardiol; 2015 Dec; 200():25-9. PubMed ID: 26404748
[TBL] [Abstract][Full Text] [Related]
17. The Inhibitory Effect of Eplerenone on Cell Proliferation in the Contralateral Kidneys of Rats with Unilateral Ureteral Obstruction.
Wang CH; Wang Z; Liang LJ; Wang XT; Ma XL; Liu BB; He JQ; Shimosawa T; Xu QY
Nephron; 2017; 136(4):328-338. PubMed ID: 28402979
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo.
Messaoudi S; Gravez B; Tarjus A; Pelloux V; Ouvrard-Pascaud A; Delcayre C; Samuel J; Launay JM; Sierra-Ramos C; Alvarez de la Rosa D; Clément K; Farman N; Jaisser F
Hypertension; 2013 Feb; 61(2):361-7. PubMed ID: 23297371
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic actions of aldosterone and the effects of eplerenone, a selective mineralocorticoid receptor antagonist.
Takeda Y
Hypertens Res; 2004 Nov; 27(11):781-9. PubMed ID: 15824460
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
Arai K; Homma T; Morikawa Y; Ubukata N; Tsuruoka H; Aoki K; Ishikawa H; Mizuno M; Sada T
Eur J Pharmacol; 2015 Aug; 761():226-34. PubMed ID: 26073023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
